We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+1.37%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$11.4B
AUM Growth
+$504M
(+4.6%)
Cap. Flow
+$402M
Cap. Flow
% of AUM
3.53%
Top 10 Holdings %
Top 10 Hldgs %
17.81%
Holding
2,458
New
259
Increased
1,134
Reduced
877
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$23.1M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$23.1M |
| 3 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$19M |
| 4 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$15.7M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$15.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$28M |
| 2 |
First Trust Smith Unconstrained Bond ETF
UCON
|
+$23.9M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$18.3M |
| 4 |
First Trust Smith Opportunistic Fixed Income ETF
FIXD
|
+$9.64M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$8.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.41% |
| 2 | Financials | 4.96% |
| 3 | Healthcare | 3.93% |
| 4 | Consumer Discretionary | 3.62% |
| 5 | Industrials | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
PIMCO RAFI Dynamic Multi-Factor US Equity ETF
MFUS
$305M
| $3.02M | 0.03% |
100,648
-12,783
| -11% | -$377K |
|
|
AGN
602
DELISTED
Allergan plc
AGN
| $3.02M | 0.03% |
17,965
+1,607
| +10% | +$262K |
|
603
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.88B
| $3.01M | 0.03% |
89,386
-560
| -0.6% | -$18.4K |
|
604
Amplify Alternative Harvest ETF
MJ
$114M
| $3M | 0.03% |
12,021
-3,735
| -24% | -$1.2M |
|
605
BlackRock Short Maturity Municipal Bond ETF
MEAR
$1.37B
| $2.99M | 0.03% |
59,673
+25,712
| +76% | +$1.29M |
|
606
Carvana
CVNA
$82.2B
| $2.97M | 0.03% |
225,240
+204,890
| +1,007% | +$2.94M |
|
|
CCIF
607
Carlyle Credit Income Fund
CCIF
$60.4M
| $2.97M | 0.03% |
+278,081
| New | +$2.85M |
|
608
Public Service Enterprise Group
PEG
$37.8B
| $2.96M | 0.03% |
47,764
+5,905
| +14% | +$353K |
|
609
iShares Mortgage Real Estate ETF
REM
$547M
| $2.96M | 0.03% |
70,150
+25,577
| +57% | +$1.08M |
|
610
Omega Healthcare
OHI
$14B
| $2.94M | 0.03% |
70,265
+1,285
| +2% | +$50K |
|
611
Alliant Energy
LNT
$18.2B
| $2.93M | 0.03% |
54,336
+7,016
| +15% | +$360K |
|
612
Lam Research
LRCX
$424B
| $2.9M | 0.03% |
125,590
-26,930
| -18% | -$565K |
|
613
American Water Works
AWK
$27.1B
| $2.9M | 0.03% |
23,363
+666
| +3% | +$80.3K |
|
614
iShares US Healthcare ETF
IYH
$3.77B
| $2.9M | 0.03% |
76,685
-29,660
| -28% | -$1.14M |
|
615
Chipotle Mexican Grill
CMG
$41.6B
| $2.89M | 0.03% |
171,700
+7,300
| +4% | +$116K |
|
616
Fidelity MSCI Financials Index ETF
FNCL
$2.43B
| $2.88M | 0.03% |
70,898
-68,717
| -49% | -$2.76M |
|
|
EXAS
617
DELISTED
Exact Sciences
EXAS
| $2.87M | 0.03% |
31,758
+456
| +1% | +$52K |
|
618
iShares MSCI Canada ETF
EWC
$6.53B
| $2.87M | 0.03% |
99,161
+13,099
| +15% | +$373K |
|
|
BSJM
619
DELISTED
Invesco BulletShares 2022 High Yield Corporate Bond ETF
BSJM
| $2.87M | 0.03% |
117,568
+19,181
| +19% | +$469K |
|
620
AstraZeneca
AZN
$244B
| $2.86M | 0.03% |
32,087
+286
| +0.9% | +$24.8K |
|
621
iShares MSCI Pacific ex Japan ETF
EPP
$2.25B
| $2.84M | 0.02% |
63,452
-7,322
| -10% | -$334K |
|
622
Ross Stores
ROST
$78.3B
| $2.83M | 0.02% |
25,756
+5,245
| +26% | +$553K |
|
623
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
| $2.83M | 0.02% |
48,513
+17,050
| +54% | +$984K |
|
624
Royal Bank of Canada
RY
$298B
| $2.81M | 0.02% |
34,581
+267
| +0.8% | +$20.8K |
|
|
MMP
625
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $2.81M | 0.02% |
42,347
+2,924
| +7% | +$193K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q3 2019 Portfolio in Review
As of Q3 2019, Cambridge Investment Research Advisors held 2,458 positions worth $11.4B, up 4.6% from $10.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors deployed $402M of net new capital in Q3 2019, opening 259 new positions and adding to 1,134 existing holdings. Its largest new stake was Invesco S&P Ultra Dividend Revenue ETF: 309,094 shares worth $11.7M.
By sector, the portfolio is most concentrated in Technology at 6.4% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $28M trimmed.
- Cambridge Investment Research Advisors's largest Q3 2019 buy was Invesco S&P Ultra Dividend Revenue ETF: 309,094 shares worth $11.7M.
- Cambridge Investment Research Advisors added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $23.1M increase.
- Cambridge Investment Research Advisors's biggest Q3 2019 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $28M.
- Cambridge Investment Research Advisors fully exited DXC Technology in Q3 2019, selling an estimated $3.71M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $11.4B portfolio in Q3 2019.
- Cambridge Investment Research Advisors opened 259 new positions and closed 119 in Q3 2019.
- Cambridge Investment Research Advisors's portfolio value rose 4.6% quarter-over-quarter to $11.4B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2019, filed 28 Oct 2019.